Cargando…
Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway
BACKGROUND: Peroxisome proliferator-activated receptor-beta/delta (PPARδ) was considered as the key regulator involved in the evolution of various tumors. Given that PPARδ potential role in hepatocellular carcinoma (HCC) is still obscure, we comprehensively assessed its expression pattern, prognosis...
Autores principales: | Han, Wei, Wang, Nan, Kong, Rui, Bao, Wen, Lu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840031/ https://www.ncbi.nlm.nih.gov/pubmed/35151320 http://dx.doi.org/10.1186/s12967-022-03288-9 |
Ejemplares similares
-
Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
por: Huang, Lu, et al.
Publicado: (2022) -
ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway
por: Ni, Sheng, et al.
Publicado: (2020) -
Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”
por: Huang, Lu, et al.
Publicado: (2022) -
Methylation-Mediated Silencing of RBP7 Promotes Breast Cancer Progression through PPAR and PI3K/AKT Pathway
por: Lin, Hong, et al.
Publicado: (2022) -
TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
por: Ye, Yanqing, et al.
Publicado: (2023)